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avoids catheters and their complications, and preserves
future access sites.
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Predicting Cognitive Decline After Carotid
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Objectives: Many carotid endarterectomy (CEA) and
carotid artery stenting (CAS) patients experience postoper-
ative neurocognitive decline. We sought to apply structural
connectivity metrics to identify patients at increased risk for
postoperative decline based solely on preoperative imaging.
Methods: Under an IRB approved protocol, 28 pa-
tients underwent presurgical T1 structural and 30 direction
diffusion tensor imaging (DTI) magnetic resonance imag-
ing and neuropsychological tests before and 1 month after
surgery. Patients with decline showed decreased perfor-
mance on the Rey Auditory Verbal Learning Test on 1-
month follow-up. The T1 images were processed using
FreeSurfer 5.3, with resulting segmentations reviewed
and edited as needed under neuroradiologist supervision.
Whole brain tractography was performed using Diffusion
Toolkit and visually inspected. Connectivity matrices
were then generated, and graph metrics were computed us-
ing the Brain Connectivity Toolbox.
Results: Controlling for age, classiﬁers using the graph
analysis metrics “weighted optimal community structure”
and “binary component sizes” were able to identify pa-
tients with postoperative cognitive decline with 81% sensi-
tivity 83% and speciﬁcity (P < .05, false discovery rate .05).
These two measures were computed at 10 proportion edge
thresholds from 0.1 to 1 at intervals of 0.1 in weighted and
binary networks respectively.
Conclusions: Applying preoperative structural con-
nectivity analysis in CEA and CAS patients may identify pa-
tients at increased risk for postoperative cognitive decline,
and in so doing may help better risk stratify patients and
guide them to preventive interventions.Table.
30-day Postoperative Outcome
Total
Symptomatic
n ¼ 5423
Women Men
n ¼ 836
37.3%
n ¼ 1406
62.7% Odd
Composite primary end point 4.9% 5.3% 6.1% 0
Death 0.7% 1.2% 0.9% 0
Stroke 2.3% 4.5% 3.8% 0
Myocardial infarction 2.5% 1.8% 2.1% 0Author Disclosures: E. Hitchner: Nothing to disclose;
M. Moseley: Nothing to disclose; G. Prasad: Nothing
to disclose; A. Rosen: Nothing to disclose; S. Soman:
Nothing to disclose; W. Zhou: Nothing to disclose.PS114.
Contemporary Results of Carotid Endarterectomy: Is
it a Beneﬁcial Procedure for Women?
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Objectives: Previous randomized trials have suggested
that carotid endarterectomy (CEA) may not be efﬁcacious
for women primarily due to higher postoperative event
rates. Our objective was to compare contemporary CEA
outcomes among women and men in a “real world”
setting.
Methods: CEA procedure related data were obtained
from the 2011-2012 American College of Surgeons
National Surgical Quality Improvement Program
(ACS-NSQIP) database. Symptomatic patients were
those with ipsilateral stroke, transient ischemic attack, or
amaurosis fugax. Patient characteristics and 30-day postop-
erative outcomes were examined for sex and
symptomatology.
Results: Of the 5423 patients with speciﬁc data on
CEA, 2242 (41.3%) were symptomatic and 3181 (58.7%)
were asymptomatic. There were a higher proportion of
women in the asymptomatic than symptomatic group
(40.3% vs 37.3%; P ¼ .025). For the entire cohort, women
were more often obese (34.1% vs 30.9%; P < .001) and a
smoker (29.5% vs 24.1%; P < .001), but less often taking
statins (75.9% vs 80.5%; P < .001) than men. Patch use
was equivalent between women and men (76.1% vs
76.8%; P ¼ .4997). After adjusting for patient characteris-
tics, there were no statistically signiﬁcant differences be-
tween women and men for postoperative death, stroke,
or myocardial infarction for symptomatic and asymptom-
atic groups (Table).
Conclusions: Analysis of this reliable third-party
collected and validated data shows that postoperative out-
comes were similar among women and men regardless of
symptom status. However, there remains ample room for
improvements in optimal medical therapy for both women
and men.Asymptomatic
For Women Women Men For Women
s ratio P-value
n ¼ 1282
40.3%
n ¼ 1899
59.7% Odds ratio P-value
.821 .331 3.9% 4.6% 0.873 .464
.960 .931 0.6% 0.4% 1.617 .390
.934 .733 1.3% 1.4% 0.924 .804
.810 .515 2.1% 3.3% 0.682 .110
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Variable Min Max
Symptomatic patients who had CAS (vs CEA), % 7 32
Asymptomatic patients who had
CAS (vs CEA), %
7 23
CEA with symptoms, % 20 42
CAS with symptoms, % 10 53
CEA with patch, % 73 95
CEA with shunt use, % 33 76
CEA where EEG used by surgeons who
routinely shunt, %
0 68
CAS on both antiplatelet and statin, % 60 82
CAS discharged on both antiplatelet and statin, % 75 91
Asymptomatic CAS with stenosis >70%, % 67 97
CAS predialated, % 27 68
CAS postdialated, % 60 96
All P < .01.PS116.
Are NASCET and ACAS Guidelines Applicable to
Modern Imaging Measurements: Digital Subtraction
Angiography vs TeraRecon CTA
Ashley Aaron, Adithya Suresh, Steven Santilli, Rumi Faizer,
Steven Levin. University of Minnesota, St. Paul, Minn
Objectives: The North American Symptomatic Ca-
rotid Endarterectomy Trial (NASCET) and Asymptomatic
Carotid Artery Surgery Trial, helped establish guidelines
for carotid intervention based on conventional angiography
measurements of stenosis. However, with improvement in
noninvasive imaging techniques, the use of computed to-
mography angiography (CTA) has become widespread.
The goal of this retrospective evaluation was to compare
the degree of carotid stenosis based on TeraRecon
compared with angiography and how these potential differ-
ences may impact decisions for intervention.
Methods: The percentage of carotid stenosis was ob-
tained via digital subtraction angiography and TeraRecon.
The study population included 58 patients who underwent
carotid artery stenting for symptomatic and asymptomatic ca-
rotid stenosis between 2006 and 2013. The TeraRecon CTA
and angiography stenosis measurements were analyzed by
Student t-test to determine if traditional NASCET angiog-
raphy determinations for intervention are applicable to CTA.
Results: TeraRecon CTA measurements of the per-
centage of carotid artery stenosis were, on average, 6.5%
higher than those based on angiography. Analysis with
the Student t-test showed a statistically signiﬁcant differ-
ence between the two measurements (P ¼ .0033).
Conclusions: Overall, we found that measurements of
percent carotid artery stenosis in asymptomatic and symp-
tomatic patients undergoing carotid stent placement were
higher when using TeraRecon CTA compared with mea-
sures with angiography. This prompts the question have
we been over-intervening on patients by using NASCET
and ACAS guidelines on patients imaged with CTA?
Author Disclosures: A. Aaron: Nothing to disclose; R.
Faizer: Nothing to disclose; S. Levin: Nothing to disclose;
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Regional Differences in Patient Selection and
Treatment of Carotid Artery Disease in the Society
for Vascular Surgery Vascular Quality Initiative (SVS
VQI)
John C. McCallum1, Thomas Curran1, Dominique B.
Buck1, Jeremy D. Darling1, Joe Schneider3, Brian W.
Nolan2, Philip P. Goodney2, Marc L. Schermerhorn1.
1Vascular Surgery, Beth Israel Deaconess Medical Center,
Boston, Mass; 2Dartmouth Hitchcock Medical Center,
Hanover, NH; 3Northwestern University Feinberg
School of Medicine, Chicago, IllObjectives: There are limited data on the regional
variation of carotid endarterectomy (CEA) and carotid
stenting (CAS). We use the Society for Vascular Surgery
Vascular Quality Initiative (SVS-VQI) to evaluate regional
differences in CEA and CAS across the United States.
Methods: We used the SVS-VQI to identify pa-
tients undergoing CEA and CAS between 2009 and
2012. Each of 14 regions was evaluated. Regions per-
forming <50 CAS were excluded, leaving nine regions.
Results: A total of 14,871 cases were performed, and a
minority of cases used CAS (vs CEA) to treat both symptom-
atic and asymptomatic disease. Substantial regional variation in
patient characteristics (eg, symptom status, stenosis >70%),
technical approach (eg, CEA vs stent, patch use, shunt use,
neurologic monitoring, cerebral protection device use and
type), and evidence-based process measures (eg, antiplatelet
and statin use, patch use) are demonstrated in the Table.
Conclusions: This ﬁrst investigation of a national clin-
ical database demonstrates signiﬁcant regional variation in
carotid disease management. Future studies on the associ-
ation of regional variation with risk-adjusted outcomes
offer the opportunity for quality improvement through
prospective identiﬁcation of best practices.Author Disclosures: D. B. Buck: Nothing to disclose; T.
Curran: Nothing to disclose; J. D. Darling: Nothing to
disclose; P. P. Goodney: Nothing to disclose; J. C.
McCallum: Nothing to disclose; B. W. Nolan: Nothing
to disclose; M. L. Schermerhorn: Endologix Inc and
Medtronic Inc, consulting fees or other remuneration (pay-
ment); J. Schneider: Nothing to disclose.PS120.
Outcomes After Early and Delayed Carotid
Endarterectomy in Patients With Symptomatic
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Objectives: To deﬁne outcomes after carotid endar-
terectomy (CEA) in symptomatic patients when operated
on #14 days after onset of symptoms or later (<14 days).
Methods: Clinical data of consecutive patients who
underwent CEA (2003-2012) for symptomatic carotid
